Nextage Therapeutics Ltd (NXTG) — Tangible Net Worth Ratio
Nextage Therapeutics Ltd (NXTG) has a Tangible Net Worth Ratio of 100.0% as of June 2022. This metric is calculated by deducting intangible assets (ILA0.00) from net assets (ILA2.36 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore NXTG net asset momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Nextage Therapeutics Ltd Tangible Net Worth Ratio (2017–2021)
This chart shows how Nextage Therapeutics Ltd's Tangible Net Worth Ratio has changed across 4 annual periods from 2017 to 2021. As of June 2022, the ratio stands at 100.0%, reflecting net assets of ILA2.36 Million with intangible assets of ILA0.00 ILA. For live market cap and overall valuation, see Nextage Therapeutics Ltd stock valuation.
Annual Tangible Net Worth Ratio for Nextage Therapeutics Ltd (2017–2021)
The table below presents the year-by-year Tangible Net Worth Ratio for Nextage Therapeutics Ltd from 2017 to 2021, covering 4 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. See how financially flexible is Nextage Therapeutics Ltd to measure the company's free cash flow as a share of total liabilities.
| Year | Tangible NW Ratio | Net Assets (ILA) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2021 | 100.0% | ILA516.00K | ILA0.00 | ILA4.27 Million | ▲ +90.9 pp |
| 2020 | 9.1% | ILA1.45 Million | ILA1.32 Million | ILA4.07 Million | ▼ -67.7 pp |
| 2019 | 76.8% | ILA3.66 Million | ILA847.00K | ILA6.01 Million | ▲ +98.4 pp |
| 2017 | -21.5% | ILA4.44 Million | ILA5.39 Million | ILA12.39 Million | — |